delta(9)-tetrahydrocannabinolic acid has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadet, JL; Darwin, WD; Herning, RI; Huestis, MA; Karschner, EL; Lowe, RH; Schwilke, EW | 1 |
1 other study(ies) available for delta(9)-tetrahydrocannabinolic acid and Cognition Disorders
| Article | Year |
|---|---|
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Topics: Biomarkers; Cognition Disorders; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Smoking; Substance Abuse Detection; Substance-Related Disorders | 2009 |